Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Biopharmaceutical Statistics"
DOI: 10.1080/10543406.2017.1378664
Abstract: ABSTRACT Multiplicity issues can be multidimensional: A confirmatory clinical trial may be designed to have efficacy assessed with two or more primary endpoints, for multiple dose groups, and at several post-baseline visits. Controlling for multiplicity… read more here.
Keywords: multiplicity; confirmatory clinical; higher dose; multiple visits ... See more keywords